(RTTNews) - OPKO Health (OPK) and Entera Bio have entered a collaboration and license agreement to develop the first oral dual agonist GLP-1/glucagon peptide for obesity, metabolic, and fibrotic ...

Opko Health and Entera Bio have formalized their partnership as the biotechs prepare to take the first orally administered dual agonist glucagonlike-peptide 1 (GLP-1)/glucagon peptide into the clinic.

Gvoke VialDx has the potential to modernize the handling and administration of glucagon for diagnostic procedures," said Kevin McCulloch, President and COO of Xeris. "American Regent is the ...

It doesn’t come in a generic version. However, glucagon (the active drug in Gvoke) is available in generic forms for intramuscular injection as an option in addition to subcutaneous use.

Based on the comprehensive data analyses, the data are considered compelling and provide new insight into the mechanisms underlying intramuscular fat deposition and muscle fiber remodeling. The study ...

Glucose homeostasis is maintained primarily by the action of the two pancreatic hormones, insulin and glucagon, in conjunction with a host of other modulators. (Röder et al., 2016). Beta- and ...